Prior Authorization

December 26, 2024

Prior Authorization: What is It and How Does It Affect Me?

Prior authorization (PA) is one of the many tools that support our mission to improve member health and lower costs. It’s a standard health care process that most pharmacy benefit managers (PBM) use to ensure you’re taking safe, cost-effective medications.

Prescriptions may need prior authorization if they:

How It Works

Drugs that need prior authorization are listed on your formulary with a PA.

If a drug requires prior authorization, more information is usually required from your prescriber before the prescription can be filled. You also may be asked to try an alternative prescription that’s already covered, if your diagnosis or situation allows.

When an alternative isn’t effective or is advised against, we’ll partner with your prescriber and plan sponsor to find a solution and get you the care you need.

Rules around prior authorization are informed by the U.S. Food and Drug Administration (FDA), your plan sponsors and the Navitus Pharmacy and Therapeutics Committee, with the goal of helping you get safe and affordable medications that work.

We know how important timely access to your medication is, so most prior authorization requests are reviewed within two business days and urgent requests within one business day.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

previous arrow
next arrow